Stockreport

Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer's disease [Yahoo! Fin...

Lindsay Corporation  (LNN) 
Last lindsay corporation earnings: 4/7 06:45 am Check Earnings Report
US:NYSE Investor Relations: lindsayir.com
PDF The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4 genetic variant using a simple blood sample. [Read more]